日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study

改良版 FOLFOXIRI 联合帕尼单抗一线治疗 RAS/BRAF 野生型转移性结直肠癌:III 期 TRIPLETE 研究的最终结果

Conca, Veronica; Rossini, Daniele; Antoniotti, Carlotta; Lonardi, Sara; Pietrantonio, Filippo; Moretto, Roberto; Antonuzzo, Lorenzo; Randon, Giovanni; Lavacchi, Daniele; Pozzo, Carmelo; Marmorino, Federica; Bergamo, Francesca; Tamburini, Emiliano; Passardi, Alessandro; Fazio, Roberta; Murgioni, Sabina; Borelli, Beatrice; Buonadonna, Angela; Germani, Marco Maria; Formica, Vincenzo; Carullo, Martina; Bordonaro, Roberto; Aprile, Giuseppe; Zaniboni, Alberto; Masi, Gianluca; Boni, Luca; Cremolini, Chiara

Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma

KEYNOTE-585研究中生存期的替代终点:新辅助/辅助帕博利珠单抗联合化疗与安慰剂联合化疗治疗胃癌或胃食管交界处腺癌的比较

Shitara, K; Bang, Y-J; Wyrwicz, L S; Rha, S Y; Oshima, T; Pietrantonio, F; Park, Y-K; Lonardi, S; Yañez, P; Yen, C-J; Metges, J-P; Garrido, M; Moehler, M; Pelles-Avraham, S; Yong, W P; Spallanzani, A; Jensen, E; Krishnan, R; Shih, C-S; Al-Batran, S-E

Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study

阿托格泮治疗偏头痛24周后的有效应答者和超有效应答者:来自GIANT-2研究的真实世界证据

Barbanti, Piero; Egeo, Gabriella; Doretti, Alberto; Pistoia, Francesca; Rinalduzzi, Steno; Strumia, Silvia; Aurilia, Cinzia; Scatena, Paola; Autunno, Massimo; Salerno, Antonio; Galli, Alberto; Altavilla, Riccardo; Messina, Stefano; Zanferrari, Carla; Bruno, Pietrantonio; Camarda, Cecilia; D'Onofrio, Florindo; Iovene, Veronica; Ranieri, Angelo; Bono, Francesco; de Souza, Jesuély Spieckert; Carnevale, Antonio; Di Clemente, Laura; Zucco, Maurizio; Bandettini Di Poggio, Monica Laura; Vinciguerra, Luisa; Borrello, Laura; Fiorentini, Giulia; Vecchio, Rosario; Drago, Valeria; Torelli, Paola; Albanese, Maria; Tomino, Carlo; Bonassi, Stefano; Porreca, Annamaria

Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer

早期局部晚期直肠癌患者的临床特征和预后

Pretta, Andrea; Giampieri, Riccardo; Ziranu, Pina; Bottelli, Andrea; Donisi, Clelia; Tiberi, Elisa; Cimbro, Erika; Randon, Giovanni; Fraschini, Matteo; Spanu, Dario; Didaci, Luca; Dell'Utri, Veronica; Pretta, Gianluca; Mariani, Stefano; Puzzoni, Marco; Pusceddu, Valeria; Berardi, Rossana; Pietrantonio, Filippo; Faa, Gavino; Scartozzi, Mario

SkitoSnack 2.0 - A Bloodmeal Alternative for Anopheles and Aedes Mosquitoes

SkitoSnack 2.0——按蚊和伊蚊的血餐替代品

Karki, Anjali; Luker, Hailey A; Potlapalli, Naga Narendra Reddy; Holguin, F Omar; Berwal, Meenakshi; Pietrantonio, Patricia V; Hansen, Immo A

Feasibility Study of Decellularized Corneal Lenticule in a Porcine Model for Macular Hole Closure.

在猪模型中应用脱细胞角膜透镜治疗黄斑裂孔的可行性研究。

Ruggeri Maria Ludovica, Pelusi Letizia, Nubile Mario, Quarta Alberto, Lamolinara Alessia, Allegretti Marcello, Faieta Samuele, Di Pietrantonio Nadia, Del Pizzo Francesco, Mastropasqua Leonardo, Pandolfi Assunta, Mandatori Domitilla, Mastropasqua Rodolfo

Efficacy and Safety of Anti-PD-(L)1 Treatments: A Systematic Review and Meta-Analysis of Asian vs Non-Asian Patients with Esophageal Squamous Cell Carcinoma

抗PD-(L)1治疗的疗效和安全性:亚洲与非亚洲食管鳞状细胞癌患者的系统评价和荟萃分析

Ajani, Jaffer; Zhan, Lin; Kadva, Alysha; Kato, Ken; Kretz, Julian; Pietrantonio, Filippo; Kelly, Ronan J; Zhang, Xiaowei; Lorenzen, Sylvie

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials

人表皮生长因子受体2在接受化疗联合贝伐单抗或抗EGFR治疗的转移性结直肠癌患者中的影响:八项随机试验的探索性分析

Germani, Marco Maria; Borelli, Beatrice; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Oldani, Simone; Battaglin, Francesca; Bergamo, Francesca; Salvatore, Lisa; Stahler, Arndt; Antoniotti, Carlotta; Shitara, Kohei; Venook, Alan; Oki, Eiji; Muro, Kei; Ugolini, Clara; Soeda, Junpei; Lonardi, Sara; Pietrantonio, Filippo; Lenz, Heinz-Josef; Modest, Dominik Paul; Yoshino, Takayuki; Cremolini, Chiara

AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.

AREG 和 EREG 是胃食管癌中 EGFR 抑制剂疗效的预测生物标志物

Conticelli Daniela, Volante Marco, Pietrantonio Filippo, Orrù Claudia, Olivero Martina, Nottegar Alessia, Borghi Felice, Baiocchi Gian L, Crotti Giovanni, Fumagalli Romario Uberto, De Manzoni Giovanni, Reddavid Rossella, Porporato Roberta, Kılıç Dinçer, Ghione Rebecca, Calabrò Erika, Petty Russell, Corso Simona, Giordano Silvia, Migliore Cristina

Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer

更正:HER2阳性间充质干细胞中CD36的富集导致乳腺癌治疗耐药

Castagnoli, Lorenzo; Franceschini, Alma; Cancila, Valeria; Dugo, Matteo; Bigliardi, Martina; Chiodoni, Claudia; Toneguzzo, Paolo; Regondi, Viola; Corsetto, Paola A; Pietrantonio, Filippo; Mazzucchelli, Serena; Corsi, Fabio; Belfiore, Antonino; Vingiani, Andrea; Pruneri, Giancarlo; Ligorio, Francesca; Colombo, Mario P; Tagliabue, Elda; Tripodo, Claudio; Vernieri, Claudio; Triulzi, Tiziana; Pupa, Serenella M